-
- Wern Hann Ng
- Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
-
- Thomas Tipih
- Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
-
- Nigel A. Makoah
- Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
-
- Jan-G Vermeulen
- Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
-
- Dominique Goedhals
- Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
-
- Joseph B. Sempa
- Department of Biostatistics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
-
- Felicity J. Burt
- Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
-
- Adam Taylor
- Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
-
- Suresh Mahalingam
- Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
-
- Diane E. Griffin
- editor
抄録
<jats:p>COVID-19 has plagued the world since it was first identified in December 2019. Previous systematic reviews and meta-analysis were limited by various factors such as the usage of non-peer reviewed data and were also limited by the lack of clinical data on a global scale.</jats:p>
収録刊行物
-
- mBio
-
mBio 12 (1), e03647-, 2021-02-23
American Society for Microbiology